Category: Steris Corp.
Here's a look at some of the top legal news stories for medical device companies this week: Could Medtronic-Covidien deal get caught in anti-inversion legislation?; Medtronic fights tax dodging rhetoric in Covidien merger; Travelers holds out on BD's $67M coverage claim; Abbott CEO defends inversions amid corporate exodus furor; Steris, Medtrica win legal fees in Cygnus Medical patent spat;
A federal judge agrees to award legal fees to Steris and Medtrica in their patent infringement win over Cygnus Medical, after a U.S. Supreme court decision reboots the rules on awarding legal costs.
FDA inspectors identify a handful of violations at Steris Isomedix's sterilization facility, including concerns that the company failed to respond appropriately to incidents in which employees were manipulating data.
Steris's (NYSE:STE) Isomedix division is in the FDA's hotseat after inspectors turned up incidents in which employees faked data on testing for medical devices.
Steris puts a ribbon on the $165 million acquisition of Integrated Medical Systems and reports its Q4 earnings, tallying a $20.5 million restructuring charge tied to the closure of its Hopkins, Ohio, manufacturing facility and the termination of 150 workers.
Ohio infection control solutions provider Steris (NYSE:STE) closed the previously reported acquisition of Integrated Medical Systems, paying about $165 million for the surgical instrument management company.
Steris expands its specialty services business with the $165 million acquisition of Integrated Medical Systems and its surgical instrument repair, management and processing services.
Steris (NYSE:STE) announced this week plans to acquire Integrated Medical Systems in a deal worth up to $175 million. Steris will pay $165 million to acquire the instrument services company, plus another $10 million for real estate, according to a press release.
Steris Corp. said it plans to shutter a plant in Ohio and lay off about 150 workers, or nearly 3% of its workforce.
Steris (NYSE:STE) said it plans to close down a plant in its Mentor, Ohio, base and lay off about 150 workers worldwide.
The layoffs represent a 2.5% cut to the workforce at Steris, which employed about 6,000 workers as of March 31, 2013, according to a regulatory filing.
Zynex CEO Thomas Sandgaard downsizes the company's board of directors as part of a larger strategy to restructure the company.
Zynex (OTC:ZYXI) CEO Thomas Sandgaard has cleared the path to reshape the company after cutting its board in half.
Sandgaard asked for the resignations of board members Mats Wahlstrom, Mary Beth Vitale, Kevin Smith and Taylor Simonton, to add board members who share Sandgaard's vision for the rehab devices maker.